The Valley Desk

ArticleRheumatology and therapyPublished

Pharmacokinetics and Safety of Ustekinumab in Patients with Juvenile Psoriatic Arthritis: Results of the Real-World Ustekinumab Pediatric Opportunistic Pharmacokinetics Study (U-POPS)

Read the publication ↗ Open access copy ↗

Regional connection

Verified An author affiliation on the Europe PMC record names Johnson & Johnson. Affiliation source

Publication record

Type
Article
Venue
Rheumatology and therapy
Published
Subject terms
Psoriatic Arthritis; Juvenile Idiopathic Arthritis; Pediatric Rheumatology; Biologicals
PubMed ID
41452420
PubMed Central ID
PMC12816458
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal